BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32279216)

  • 1. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis.
    Lee GKH; Chen VH; Tan CH; Leow AST; Kong WY; Sia CH; Chew NWS; Tu TM; Chan BPL; Yeo LLL; Sharma VK; Tan BYQ
    J Thromb Thrombolysis; 2020 Oct; 50(3):724-731. PubMed ID: 32279216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
    Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
    Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
    Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
    Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
    Posch F; Königsbrügge O; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2015 Sep; 136(3):582-9. PubMed ID: 26210891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis.
    Nepal G; Kharel S; Bhagat R; Ka Shing Y; Ariel Coghlan M; Poudyal P; Ojha R; Sunder Shrestha G
    Acta Neurol Scand; 2022 Jan; 145(1):10-23. PubMed ID: 34287841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of direct oral anticoagulants in cerebral venous thrombosis: a systematic review.
    Sheng S; Nalleballe K; Pothineni NV; Sharma R; Brown A; Elkhider H; Ranabothu S; Kapoor N; Patrice KA; Onteddu S
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):501-505. PubMed ID: 32941197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis.
    Mariani MV; Magnocavallo M; Straito M; Piro A; Severino P; Iannucci G; Chimenti C; Mancone M; Rocca DGD; Forleo GB; Fedele F; Lavalle C
    J Thromb Thrombolysis; 2021 Feb; 51(2):419-429. PubMed ID: 33044735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
    Mai V; Bertoletti L; Cucherat M; Jardel S; Grange C; Provencher S; Lega JC
    PLoS One; 2019; 14(4):e0214134. PubMed ID: 30933993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience.
    Bajko Z; Maier S; Motataianu A; Filep RC; Stoian A; Andone S; Balasa R
    Acta Neurol Belg; 2022 Feb; 122(1):105-111. PubMed ID: 33733345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis.
    Giles JA; Balasetti VKS; Zazulia AR
    Neurocrit Care; 2021 Dec; 35(3):783-788. PubMed ID: 34046861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis.
    Yaghi S; Saldanha IJ; Misquith C; Zaidat B; Shah A; Joudi K; Persaud B; Abdul Khalek F; Shu L; de Havenon A; Mistry EA; Bakradze E; Goldstein ED; Reagan J; Theodorou A; Palaiodimou L; Furie K; Field TS; Tsivgoulis G; Mac Grory B
    Stroke; 2022 Oct; 53(10):3014-3024. PubMed ID: 35938419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events.
    Cordero A; Ferreiro JL; Bertomeu-González V; Rodríguez-Mañero M; Fácila L; Escribano D; Sanchez-Recalde A; Zuazola P; Ruiz-Nodar JM; González-Juanatey JR
    J Cardiovasc Pharmacol; 2021 Feb; 77(2):164-169. PubMed ID: 33351537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.
    Bose G; Graveline J; Yogendrakumar V; Shorr R; Fergusson DA; Le Gal G; Coutinho J; Mendonça M; Viana-Baptista M; Nagel S; Dowlatshahi D
    BMJ Open; 2021 Feb; 11(2):e040212. PubMed ID: 33593766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis of Direct Oral Anticoagulants Compared With Vitamin K Antagonist for Left Ventricle Thrombus.
    Mir T; Sattar Y; Attique HB; Hussain T; Alraies MC; Sheikh M; Qureshi WT
    Cardiovasc Revasc Med; 2022 Feb; 35():141-146. PubMed ID: 33722539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis.
    Hsu A; Mistry H; Lala N; Reagan JL
    Clin Neurol Neurosurg; 2020 Nov; 198():106204. PubMed ID: 32937276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.